Peik Peuranheimo , Hanna-Riikka Kreivi , Jukka Ollgren , Satu Strausz , Tuula Vasankari , Toni Ruoranen , Hanna M. Ollila , Anne Hillamaa , Sanna Toppila-Salmi , Tiina Mattila
{"title":"Increasing incidence and burden of obstructive sleep apnoea in the Finnish population: A cohort study from 2005 to 2019","authors":"Peik Peuranheimo , Hanna-Riikka Kreivi , Jukka Ollgren , Satu Strausz , Tuula Vasankari , Toni Ruoranen , Hanna M. Ollila , Anne Hillamaa , Sanna Toppila-Salmi , Tiina Mattila","doi":"10.1016/j.rmed.2025.108155","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obstructive sleep apnoea (OSA) is a significant public health problem. We sought to characterize the typical features of patients with OSA and to study the burden and treatment of OSA in Finland from 2005 to 2019.</div></div><div><h3>Methods</h3><div>Our data included adult patients with OSA (n = 50 317) treated in 2005–2019 in secondary care in the Hospital District of Helsinki and Uusimaa (HUS). We collected diagnosis and procedure codes and healthcare contacts from HUS data lake. Word search from patient records included body mass index (BMI), smoking status, Epworth Sleepiness scale (ESS), apnoea-hypopnea-index (AHI), continuous positive airway pressure (CPAP) treatment, and Mallampati score. ResMed Airview program was used to calculate the prevalence of CPAP treatment in 2018–2022.</div></div><div><h3>Findings</h3><div>The annual incidence of OSA increased from 99 per 100 000 to 564 per 100 000 (+470 %) during 2005–2019. The most significant increase in healthcare contacts occurred in remote care and nurse visits from 336 to 35 959 per year (+10 602 %) and from 1051 to 23 609 per year (+2146 %), respectively. The prevalence of CPAP treatment increased from 0·74 % to 2·48 % during 2018–2022 (+235 %).</div></div><div><h3>Interpretation</h3><div>As the prevalence of OSA is increasing, the need for more efficient treatment protocols was seen as a shift towards telemedicine and as an increase in nurse visits. Data lake offers an efficient way to analyse large data sets of OSA patient characteristics and treatment strategies.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"244 ","pages":"Article 108155"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125002173","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Obstructive sleep apnoea (OSA) is a significant public health problem. We sought to characterize the typical features of patients with OSA and to study the burden and treatment of OSA in Finland from 2005 to 2019.
Methods
Our data included adult patients with OSA (n = 50 317) treated in 2005–2019 in secondary care in the Hospital District of Helsinki and Uusimaa (HUS). We collected diagnosis and procedure codes and healthcare contacts from HUS data lake. Word search from patient records included body mass index (BMI), smoking status, Epworth Sleepiness scale (ESS), apnoea-hypopnea-index (AHI), continuous positive airway pressure (CPAP) treatment, and Mallampati score. ResMed Airview program was used to calculate the prevalence of CPAP treatment in 2018–2022.
Findings
The annual incidence of OSA increased from 99 per 100 000 to 564 per 100 000 (+470 %) during 2005–2019. The most significant increase in healthcare contacts occurred in remote care and nurse visits from 336 to 35 959 per year (+10 602 %) and from 1051 to 23 609 per year (+2146 %), respectively. The prevalence of CPAP treatment increased from 0·74 % to 2·48 % during 2018–2022 (+235 %).
Interpretation
As the prevalence of OSA is increasing, the need for more efficient treatment protocols was seen as a shift towards telemedicine and as an increase in nurse visits. Data lake offers an efficient way to analyse large data sets of OSA patient characteristics and treatment strategies.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.